Search CHA
Drug Safety Executive Council
Home
Site Map
Site Map
Site Map
About CHA
Our Mission
Strategic Business Planning
Innovation Acceleration Services
CHA Collaborative Projects
Management Team
Charlie Hoban, Chief Executive Officer
Eugene Williams, Founder, Strategic Advisor
Andrew Branca, SVP, Strategic Research
Ernie Bush, Ph.D., VP & Scientific Director (formerly F. Hoffman-La Roche)
Eric Glazer, VP, Marketing
Eric Meyers, VP, Global Initiatives
Frank Attardo, Project Director (formerly Hewlett Packard)
Haizhou Zhang, Ph.D., VP, China Operations (formerly Boehringer Ingelheim)
Guido Grentzmann, Ph.D. (formerly with Altana)
Jack A. Reynolds, D.V.M. (formerly with Pfizer)
Ellen Sheehy
John Donovan (formerly Wyeth)
Careers
About Collaborative Projects
Current Collaborative Projects - Enrollment Open
Evaluating Preclinical Cardio-Toxicity Assessment Tools
Leveraging Biomarker & Translational Research in China
Assessing GLP Compliance and Quality Practices in China
Exploiting Legacy Safety Studies
Assessing the Asian Supply Chain of Non-Human Primates (NHPs)
Case Studies of Past CHA Projects
Conducting Preclinical Safety Studies in China
Consensus Protocol for Human Sample Collection
Toxicokinetics (TK) Optimization
Events
On Demand Webinar: Emerging Impact of Zebrafish Technology on Preclinical Safety Decision Making
On Demand Webinar: The Impact of the Covance-WuXi Joint Venture
On-Demand Webinar: The Adoption of Novel Technologies in the Preclinical R&D Process
On Demand Webinar: Collaborating to Improve R&D Economics - A Call to Action
On Demand Webinar: Strategies for Leveraging Preclinical Capabilities in China -June 24 @ 8:00 AM
On Demand Webinar: Strategies for Leveraging Preclinical Capabilities in China -June 24 @ 2:00 PM
Research
Animal Sourcing in China: Benchmarking Study
In Vitro Cardiotoxicity Assessment: Benchmarking Study
Contact Us
Directions
Contact Us
Site Map
Privacy Policy
Terms of Use
Search
